mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach
The US Food and Drug Administration (FDA) has recently issued an Emergency Use
Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines …
Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines …
Maintaining safety with SARS-CoV-2 vaccines
MC Castells, EJ Phillips - New England Journal of Medicine, 2021 - Mass Medical Soc
Allergic Reactions to Covid-19 Vaccine The vast majority of people who have received the
Covid-19 vaccine to date have had self-limited local or low-grade systemic reactions that …
Covid-19 vaccine to date have had self-limited local or low-grade systemic reactions that …
[PDF][PDF] Drug allergy: a 2022 practice parameter update
Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …
committed to ensuring that all guidelines are based on the best scientific evidence at the …
Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system
Importance As of May 2021, more than 32 million cases of COVID-19 have been confirmed
in the United States, resulting in more than 615 000 deaths. Anaphylactic reactions …
in the United States, resulting in more than 615 000 deaths. Anaphylactic reactions …
Adverse events following COVID-19 vaccination: A systematic review and meta-analysis
Background High speed of COVID-19 vaccination has raised some concerns about the
safety of the new vaccines. It is of a great importance to perform a review of the safety and …
safety of the new vaccines. It is of a great importance to perform a review of the safety and …
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
KA Risma, KM Edwards, DS Hummell, FF Little… - Journal of Allergy and …, 2021 - Elsevier
Anaphylaxis to vaccines is historically a rare event. The coronavirus disease 2019 pandemic
drove the need for rapid vaccine production applying a novel antigen delivery system …
drove the need for rapid vaccine production applying a novel antigen delivery system …
Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper
Background Anaphylaxis, which is rare, has been reported after COVID‐19 vaccination, but
its management is not standardized. Method Members of the European Network for Drug …
its management is not standardized. Method Members of the European Network for Drug …
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation
Following the emergency use authorization of the mRNA‐1273 vaccine on the 18th of
December 2020, two mRNA vaccines are in current use for the prevention of coronavirus …
December 2020, two mRNA vaccines are in current use for the prevention of coronavirus …
Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines
DK Shay, TT Shimabukuro, F DeStefano - JAMA cardiology, 2021 - jamanetwork.com
Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …
Vaccine delivery systems toward lymph nodes
Strategies of improving vaccine targeting ability toward lymph nodes have been attracting
considerable interest in recent years, though there are remaining delivery barriers based on …
considerable interest in recent years, though there are remaining delivery barriers based on …